Lupus (systemic lupus erythematosus, SLE) is an autoimmune disease in which the body's immune system mistakenly attacks its own tissues, particularly affecting joints, skin, kidneys, and the nervous system.
Lupus (systemic lupus erythematosus, SLE) is an autoimmune disease in which the body's immune system mistakenly attacks its own tissues, particularly affecting joints, skin, kidneys, and the nervous system. The condition arises when B cells and T cells lose tolerance to self-antigens, producing damaging antibodies and inflammatory cytokines. Placental mesenchymal stem cells show promise because they release immunomodulatory factors—interleukins, soluble HLA-G, and exosomes containing regulatory microRNAs—that rebalance Th17 and regulatory T-cell populations. Early-stage clinical research (47 registered trials, 6 currently recruiting) suggests this approach may reduce disease activity scores and improve organ function in selected patients, though long-term remission rates remain under investigation.
| 指示性成本 · 保加利亚 (EU) | €3,000–€8,000 |
|---|---|
| 全球市场成本范围 | €9,200–€23,000 (dvcstem.com) |
| 研究的主要细胞类型 | 羊膜膜中的间充质干细胞 |
| 批准状态 | 研究性 |
| 注册的临床试验 (ClinicalTrials.gov) | 47 · 6 recruiting now |
For the clinic's own description, see our partner clinic Stem Plus.
Registered trial data spans phase I safety through phase II efficacy work across global centres. Representative studies report disease activity index improvements in 60–75% of infused cohorts over 12 months, with renal histology stabilisation in 40–55% of lupus nephritis cases. Cytokine profiling shows durable reduction in pro-inflammatory markers (TNF-α, IL-6) persisting 6–9 months post-infusion. No completed phase III pivotal trial has yet reported, making this investigational rather than standard-of-care.
Depending on assessment, a Lupus (SLE) protocol may draw on:
Lupus stem-cell protocols in Sofia clinics typically range €4,500–7,500, reflecting multiple intravenous or intra-articular administrations (2–4 infusions over 6 months), imaging surveillance, and immunological monitoring. Regional variation reflects cell source (umbilical cord, bone marrow, or placental) and expansion methodology. Insurance rarely covers experimental protocols, and travel costs for international treatment add substantially to out-of-pocket expenses.
Indicative EU treatment cost is €3,000–€8,000 versus roughly €15,000–35,000 in the US or Germany. Build your real all-in total with the cost calculator, see the Lupus (SLE) cost-by-country breakdown, or compare the best countries for Lupus (SLE) →
Before booking, check safety & regulation, the recovery climate, 您是否可能是候选人, and which cell type fits Lupus (SLE).
完整狼疮（SLE）常见问题 → · 狼疮（SLE）成本分解 →
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
Useful tools & guides: 我是候选人吗？ · 哪种细胞类型？ · Types of clinics & best countries · 成本计算器
由 StemCellAtlas 的编辑团队进行医学审查，与Dr Polina Krasenova (Haematologist · Clinical Haematology & Integrative Oncology · 15+ yrs cell therapy) 合作诊所 Stem Plus（索菲亚）的，根据 ISSCR、FDA 和 EMA 指南。 Educational information, not medical advice; figures indicative.
位于欧盟核心的 GMP 认证再生医学诊所——费用 3,000–8,000 欧元起，仅为美国或德国价格的一小部分。为来自 50 多个国家的国际患者提供个性化方案。
免费医疗评估